首页> 外文期刊>Surgical laparoscopy, endoscopy and percutaneous techniques >Complications of metallic stent placement in malignant esophageal stricture and their management.
【24h】

Complications of metallic stent placement in malignant esophageal stricture and their management.

机译:食管恶性狭窄中金属支架置入术的并发症及其处理。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: At the present time, covered self-expandable metallic stent placement is the palliative treatment method for inoperable esophageal cancer. However, life-threatening early and late complications are seen related to esophageal stent placement. In this study, we discuss complications of esophageal stent placement with their management and present our own experience. METHODS: Between January 2000 and February 2009, 215 covered esophageal stent placements were performed in 174 inoperable esophageal cancer and/or esophagorespiratory fistula patients in the Department of Thoracic Surgery at the Ataturk University Hospital. RESULTS: Major complications related to stent placement developed in 24 patients (11 bleeding, 6 aspiration pneumonia, 3 tracheal compressions, 2 perforations, and 2 esophagorespiratory fistulas). Two hundred and thirty minor complications were observed among 174 patients (165 chest pain, 29 tumoral overgrowth, 17 stent migration, 6 gastroesophageal reflux, 3 failure in stent placement, 3 hiccup, 2 foreign body sensation, 2 failure in stent expansion, 1 tumor ingrowth, 1 granulation tissue formation, and 1 food bolus obstruction). Reintervention was required in 56 (32.2%) patients who experienced complications. Stent-related mortality was seen in 4 (2.3%) patients (2 aspiration pneumonia, 1 tracheal compression, and 1 esophagorespiratory fistula). One hundred sixty-two of 174 patients died during follow up. The mean survival time was 177.3+/-59.3 days (range: 2 to 993 d). CONCLUSIONS: The complication rate of self-expandable metallic stent placement is high in inoperable esophageal cancer patients. Although some of these complications are life threatening, many of them can be managed successfully with endoscopic reintervention.
机译:目的:目前,有盖自膨胀金属支架置入术是无法手术的食管癌的姑息治疗方法。但是,可以看到危及生命的早期和晚期并发症与食管支架置入有关。在这项研究中,我们讨论了食管支架置入术的并发症及其处理方法,并介绍了我们自己的经验。方法:在2000年1月至2009年2月期间,对阿塔图尔克大学医院胸外科的174例无法手术的食道癌和/或食道呼吸道瘘管患者进行了215次有盖食管支架置入术。结果:24例患者发生了与支架置入有关的主要并发症(11例出血,6例吸入性肺炎,3例气管压迫,2例穿孔和2例食管呼吸性瘘)。在174例患者中观察到了230例轻微并发症(165例胸痛,29例肿瘤过度生长,17例支架移位,6例胃食管反流,3例支架置入失败,3例打h,2例异物感,2例支架扩张失败,1例肿瘤)向内生长,1个肉芽组织形成和1个食物团块阻塞)。 56名(32.2%)发生并发症的患者需要再次干预。与支架相关的死亡率见于4名患者(2.3%)(2例吸入性肺炎,1例气管压迫和1例食管呼吸性瘘)。 174例患者中有162例在随访期间死亡。平均生存时间为177.3 +/- 59.3天(范围:2至993 d)。结论:不能手术的食管癌患者自扩张金属支架置入的并发症发生率较高。尽管其中一些并发症危及生命,但通过内镜再介入可以成功治疗其中许多并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号